Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
Press Releases
Soligenix, Inc.  
April 14, 2025

Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks

Interim Results from FDA-Funded Study Reinforces HyBryte's™ Rapid Response and Strong Safety Profile

logo salamanca press

Salamanca Press

Local & Social